The independent association found in our study between plasma chemerin levels and blood pressure values extends the experimental evidence regarding the vasoconstrictor actions of chemerin, hinting that upregulation of vascular chemerin signaling plays a role in obesity-related hypertension. Here, RARRES2 is linked to obesity disorder.